Developing human antibodies to fight COVID-19
Human antibody-based countermeasures against the Wuhan Coronavirus SARS-CoV-2
This study is looking at how certain antibodies from people who have recovered from COVID-19 can help fight the virus, with the goal of creating new treatments to keep patients from getting very sick.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10902121 on NIH RePORTER |
What this research studies
This research focuses on creating and testing human monoclonal antibodies that can neutralize the SARS-CoV-2 virus, which causes COVID-19. The team will collect antibodies from individuals who have recovered from COVID-19 and analyze their effectiveness against the virus. By understanding how these antibodies bind to the virus, the researchers aim to develop treatments that could be used to prevent severe illness in patients. The project involves collaboration among experts to ensure rapid progress in developing these therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are at high risk for severe COVID-19, such as the elderly or those with compromised immune systems.
Not a fit: Patients who are not at risk for severe COVID-19 or those who have already been vaccinated may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective antibody treatments that reduce the severity of COVID-19 and save lives.
How similar studies have performed: Other research has successfully developed antibody therapies for viral infections, indicating that this approach has potential for success.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Diamond, Michael S — Washington University
- Study coordinator: Diamond, Michael S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.